Phase 1 Knee Arthroplasty Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Methylene Blue in Total Knee Arthroplasty (TKA)
Total Knee Arthroplasty
University of Miami20 enrolled1 locationNCT07324954
Recruiting
Phase 1Phase 2
Intraosseous (IO) Cefazolin and Vancomycin in Primary Total Knee Arthroplasty (TKA)
Total Knee Arthroplasty
The Methodist Hospital Research Institute40 enrolled1 locationNCT06640491
Recruiting
Phase 1Phase 2
Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan
Knee Arthroplasty, Total
Steadman Philippon Research Institute120 enrolled1 locationNCT06108063
Not Yet Recruiting
Phase 1
Concentration of prophylactic intraosseous regional vancomycin administration prior to total knee arthroplasty in the obese patient
Infection following total knee arthroplasty
Seung Joon Chin22 enrolled1 locationACTRN12614001297617